Langerhans' cells (LC) are dendritic, antigen-presenting cells present within the epithelium of skin and mucosa, including that of the oral cavity. This article reviews the literature on the phenotypic and functional features of oral mucosal Langerhans' cells, and speculates on other aspects by extrapolating from data on their epidermal counterparts.
References
1.
Aiba S., Katz SI ( 1991). The ability of cultured Langerhans cells to process and present protein antigens is MHCdependent. J Immunol146:2479-2487.
2.
Aiba S., Nakagawa S., Ozawa H., Miyake K., Yagita H., Tagami H. (1993). Up-regulation of α4 integrin on activated Langerhans cells: analysis of adhesion molecules on Langerhans cells relating to their migration from skin to draining lymph nodes. J Invest Dermatol100:143-147.
3.
Amiot M., Dastot H., Fabbi M., Degos L., Bernard A., Boumsell L. (1988). Intermolecular complexes between three human CD1 molecules on normal thymus cells. Immunogenetics27:187-195.
4.
Arenberger P., Kemeny L., Rupec R., Bieber T., Ruzicka T. (1992). Langerhans cells of the human skin possess high-affinity 12(S)-hydroxyeicosa tetraenoic acid receptors. Eur J Immunol22:2469-2472.
5.
Ashworth J., Kahan MC, Breathnach SM (1989). Flow cytometric analysis and sorting of HLADR+/CDla+ Langerhans cells. Br J Dermatol121:11-18.
6.
Athanasas-Platsis S., Savage NW, Winning TA, Walsh LJ (1995). Induction of the CDla Langerhans cell marker on human monocytes. Arch Oral Biol40:157-160.
7.
Barrett AW, Williams DM, Scott J. (1991). Effect of tobacco and alcohol consumption on the Langerhans cell population of human lingual epithelium determined using an antibody against HLADR. J Oral Pathol Med21:771-774.
8.
Barrett AW, Ross DA, Goodacre JA (1993). Purified human oral mucosal Langerhans cells function as accessory cells in vitro. Clin Exp Immunol92:158-163.
9.
Barrett AW, Beynon AD, Reid DJ ( 1994). A comparative study on tissue processing procedures for the immunohistochemical investigation of oral mucosal Langerhans cells. Histochem J26:134-141.
10.
Barrett AW, Ross DA, Goodacre JA (1995). Limitations of flow cytometry in the investigation of human oral mucosal Langerhans cells. Oral Diseases1:49-53.
11.
Barton SE, Maddox PH, Jenkins J., Edwards R., Cuzick J., Singer A. (1988). Effect of smoking on cervical epithelial immunity: a mechanism for neoplastic change? Lancet2:652-654.
12.
Bartosik J. ( 1992). Cytomembrane-derived Birbeck granules transport horseradish peroxidase to the endosomal compartment of the human Langerhans cells. J Invest Dermatol499:53-58.
13.
Becker J., Ulrich P., Kunze R., Gelderblom H., Langford A., Reichart P. (1988). Immunohistochemical detection of HIV structural proteins and distribution of T-lymphocytes and Langerhans cells in the oral mucosa of HIV infected patients. Virchows Arch412(A):413-419.
14.
Bergfelt L., Emilson A., Lindberg M., Scheynius A. (1994). Quantitative and 3-dimensional analysis of Langerhans cells in basal cell carcinoma. A comparative study using light microscopy and confocal laser scanning microscopy. Br J Dermatol130:273-280.
15.
Bieber T., Rieger A., Stingl G., Sander E., Wanek P., Strobel I. (1992). CD69, an early activation antigen on lymphocytes, is constitutively expressed by human epidermal Langerhans cells. J Invest Dermatol98:771-776.
16.
Bieber T., Jurgens M., Wollenberg A., Sander E., Hanau D., de la Salle H. (1995). Characterisation of the protein tyrosine phosphatase CD45 on human epidermal Langerhans cells. Eur J Immunol25:317-321.
17.
Birbeck MS, Breathnach AS, Everall JD (1961). An electron microscopic study of basal melanocytes and high level clear cells Langerhans cells] in vitelligo. J Invest Dermatol37:51-64.
18.
Blauvelt A., Katz SI, Udey MC ( 1995). Human Langerhans cells express E-cadherin. J Invest Dermatol104:293-296.
19.
Blumberg RS, Terhorst C., Bleicher P., et al. (1991). Expression of a non-polymorphic MHC class 1-like molecule, CD1d, by human intestinal epithelial cells. J Immunol147:2518-2524.
20.
Blumberg RS, Yockey CE, Gross GG, Ebert EC, Balk SP ( 1993). Human intestinal lymphocytes are derived from a limited number of T-cell clones that utilise multiple Vβ T-cell receptor genes. J Immunol150:5144-5153.
21.
Braathen LR, Thorsby E. (1983). Human epidermal Langerhans cells are more potent than blood monocytes in inducing some antigen-specific T-cell responses. Br J Dermatol108:139-146.
22.
Bucana CD, Munn CG, Song M.), Dunner K. Jr, Kripke ML (1992). Internalisation of la molecules into Birbeck granule-like structures in murine dendritic cells. J Invest Dermatol99:365-373.
23.
Bujdoso R., Hopkins J., Dutia BM, Young P., McConnell I. (1989). Characterisation of sheep afferent lymph dendritic cells and their role in antigen carriage. J Exp Med170:1285-1302.
24.
Calabi F., Bradbury A. (1991). The CD1 system. Tissue Antigens37:1-9.
25.
Caux C., Dezutter-Dambuyant C., Schmitt D., Banchereau J. (1992). GM-CSF and TNFa cooperate in the generation of dendritic Langerhans cells. Nature360:258-261.
26.
Caux C., Vanberliet B., Massacrier C., et al. (1994a). B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. I Exp Med180:1841-1847.
27.
Caux C., Massacrier C., Vanberliet B., et al. (1994b). Activation of human dendritic cells through CD40 cross-linking. J Exp Med180:1263-1272.
28.
Chang CH, Furue M., Tamaki K. (1995). B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-gamma or by interleukin-10. Eur Immunol25:394-398.
29.
Charbit Y., Monteil RA, Hitzig C., Sauget P., Benaiche N., Jasmin JR (1986). S100 immunolabelling of Langerhans cells in oral epithelium. J Oral Pathol15419-422.
30.
Cimarelli A., Zambruno G., Marconi A., Girolomoni G., Bertazzoni U., Giannetti A. (1994). Quantitation by competitive PCR of HIV-1 proviral DNA in epidermal Langerhans cells of HIV-infected patients. J AIDS7230-235.
31.
Concha M. Vidal A., Garces G., Figueroa CD, Caorsi I. (1993). Physical interaction between Langerhans cells and T-lymphocytes during antigen presentation in vitro. J Invest Dermatol100:429-434.
32.
Crawford JM, Krisko JM, Morris GA, Chambers DA (1989). The distribution of Langerhans cells and CD1a antigen in healthy and diseased human gingiva. Reg Immunol2:91-97.
33.
Cruchley AT, Speight PM, Williams DM (1987). Dual expression of HLADR and CD1 [T6] on Langerhans cells in human buccal mucosa and skin. Arch Oral Biol32:849-853.
34.
Cruchley AT, Williams DM, Farthing PM, Lesch CA, Squier CA (1989). The regional expression in Langerhans cell distribution and density in normal human oral mucosa determined using monoclonal antibodies against CD1, HLADR, HLADQ and HLADP. J Oral Pathol Med18:510-516.
35.
Cruchley AT, Williams DM, Farthing PM, Speight PM, Lesch CA, Squier CA (1994). Langerhans cell density in normal human oral mucosa and skin: relationship to age, smoking and alcohol consumption. J Oral Pathol Med23:55-59.
36.
Cumberbatch M., Kimber I. (1992). Dermal tumour necrosis factor-a induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration. Immunology75:257-263.
37.
Cumberbatch M., Illingworth I., Kimber I. (1991 a). Antigen-bearing dendritic cells in the draining lymph nodes of contact sensitised mice. Immunology74:139-145.
38.
Cumberbatch M., Gould SJ, Peters SW, Kimber I. (1991b). MHC class II expression by Langerhans cells and lymph node dendritic cells: possible evidence for maturation of Langerhans cells following contact sensitisation. Immunology74:414-419.
39.
Cumberbatch M., Fielding I., Kimber I. (1994). Modulation of epidermal Langerhans' cell frequency by tumour necrosis factor-a. Immunology81:395-401. Czernielewski JM, Demarchez M. (1987). Further evidence for the self-reproducing capacity of Langerhans cells in human skin. J Invest Dermatol88:17-20.
Dai R., Grammer SF, Streilein JW (1993). Fresh and cultured Langerhans cells display differential capacities to activate hapten-specific T-cells. J Immunol150:59-66.
42.
Dandie GW, Watkins FY, Ragg SJ, Holloway PE, Muller HK (1994). The migration of Langerhans' cells into and out of lymph nodes draining normal, carcinogen and antigen-treated sheep skin. Immunol Cell Biol72:79-86.
43.
Daniels TE (1984). Human mucosal Langerhans cells: post-mortem identification of regional variations in oral mucosa. ) J Invest Dermatol84:21-24.
44.
Daniels TE, Schwartz O., Larsen V., Dabelsteen E., Pindborg J. (1985). Langerhans cells in candidal leukoplakia. J Oral Pathol14:733-739.
45.
Daniels TE, Greenspan D., Greenspan JS, Lennette E., Schiodt M., Petersen V., et al. (1987). Absence of Langerhans cells in hairy leukoplakia. I Invest Dermatol89:178-182.
46.
Daniels TE, Chou L., Greenspan JS, Grady DG, Hauck WW, Greene JC, et al. (1992). Reduction of Langerhans cells in smokeless tobacco-associated oral mucosal lesions. J Oral Pathol Med21:100-104.
47.
de Jong Mcjm, Blanken R., Nanninga J., van Voorst Vader PC, Poppema S. (1986). Defined in situ enumeration of T6 and HLA-DR-expressing epidermal Langerhans cells: morphologic and methodologic aspects. J Invest Dermatol87:698-702.
48.
de Panfilis G., Soligo D., Manara GC, Ferrari C., Torresani C., Zucchi A. (1990). Human resting epidermal Langerhans cells do express the type 3 complement receptor. Br J Dermatol122:127-136.
49.
Demarchez M., Asselineau D., Czernielewski J. (1993). Migration of Langerhans cells into human epidermis of "reconstructed" skin, normal skin, or healing skin, after grafting onto the nude mouse. I Invest Dermatol100:648-652.
50.
Dezutter-Dambuyant C., Schmitt D., Faure M., Cordier G., Thivolet J. (1984). Detection of OKT6-positive cells (without visible Birbeck granules) in normal peripheral blood. Immunol Lett8:121-126.
51.
Dezutter-Dambuyant C., Schmitt D., Staquet M-J., Boumsell L., Thivolet J. (1989). Cleavage of Langerhans cell surface CD1a molecule by trypsin. Res Immunol140:377-390.
52.
DiFranco CF, Toto PD, Rowden G., Gargiulo AW, Keene JJ, Connelly E. (1985). Identification of Langerhans cells in human gingival epithelium. J Periodontol56:48-54.
53.
Emile J.-F, Fraitag S., Leborgne M., De Prost Y., Brousse N. (1994). Langerhans' cell histiocytosis cells are activated Langerhans' cells. J Pathol174:71-76.
54.
Engel P., Tedder TF (1994). New CD from the B cell section of the Fifth International Workshop on human leukocyte differentiation antigens. Leukemia and Lymphoma13(Suppl 1 ):61-64.
55.
Enk AH, Katz SI ( 1992). Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA89:1398-1402.
56.
Enk AH, Katz SI ( 1994). Heat-stable antigen is an important costimulatory molecule on epidermal Langerhans' cells. J Immunol152:3264-3270.
57.
Enk AH, Angeloni VL, Udey MC, Katz SI ( 1993). An essential role for Langerhans cell-derived IL- 1β in the initiation of primary immune responses in skin. J lmmunol150:3698-3704.
58.
Falck B., Andersson L., Mikulowska A., Ronquist G. (1993). a-amino-n-butyric acid methyl ester induces concentrative uptake of L-dopa in human Langerhans' cells normally not operative for L-dopa transport. Acta Dermatol-Venereol73:197-199.
59.
Fartasch M., Vigneswaran N., Diepgen TL, Hornstein OP (1990). Immunohistochemical and ultrastructural study of histiocytosis X and non-X histiocytoses. J Am Acad Dermatol23:885-892.
60.
Farthing PM, Matear P., Cruchley AT (1990). The activation of Langerhans cells in oral lichen planus. J Oral Pathol Med19:81-85.
61.
Farthing PM, Matear P., Cruchley AT (1992). Langerhans cell distribution and keratinocyte expression of HLADR in oral lichen planus. J Oral Pathol Med21:451-455.
62.
Flotte TJ, Murphy GF, Bhan AK ( 1984). Demonstration of T200 on human Langerhans cell surface membranes. J Invest Dermatol82:535-537.
63.
Freudenthal P., Bhardwaj N. (1990). Dendritic cells in human blood and synovial exudates. Int Rev Immunol6:103-116.
64.
Furue M., Nindl M., Kawabe K., Nakamura K., Ishibashi Y., Sagawa K. (1992). Epitopes for CD1a, CD1b, and CD1c antigens are differentially mapped on Langerhans cells, dermal dendritic cells, keratinocytes, and basement membrane zone in human skin. J Am Acad Dermatol27:419-426.
65.
Gabrilovich DI, Woods GM, Patterson S., Harvey JJ, Knight SC (1994). Retrovirus-induced immunosuppression via blocking of dendritic cell migration and down-regulation of adhesion molecules. Immunology82:82-87.
66.
Girolomoni G., Zambruno G., Manfredini R., et al. (1994). Expression of B7 costimulatory molecule in cultured human epidermal Langerhans cells is regulated at the mRNA level. J Invest Dermatol103:54-59.
67.
Goordyal P., Isaacson PG (1985). Immunocytochemical characterization of monocyte colonies of human bone marrow: a clue to the origin of Langerhans cells and interdigitating reticulum cells. J Pathol146:189-195.
68.
Gothelf Y., Hanau D., Tsur H., Sharon N., Sahar E., Cazenave J-P., et al. (1988). T6 positive cells in the peripheral blood of burn patients: are they Langerhans cells precursors? J Invest Dermatol90:142-148.
Hage C., Willman CL, Favara BE, Isaacson PG (1993). Langerhans' cell histiocytosis (histiocytosis X): immunophenotype and growth fraction. Hum Pathol24:840-845.
71.
Haimoto H., Hosoda S., Kato K. ( 1987). Differential distribution of immunoreactive S100α and S100β proteins in normal non-nervous human tissues. Lab Invest57:489-498.
72.
Halliday GM, Lucas AD (1993). Protein kinase C transduces the signal for Langerhans' cell migration from the epidermis. Immunology79:621-626.
73.
Halliday GM, McArdle JP, Knight BA, Muller HK (1986). New methodology for assessment of the Langerhans cell network. J Pathol148:127-134.
74.
Halliday GM, Lucas AD, Barnetson RS (1992). Control of Langerhans' cell density by a skin tumour-derived cytokine. Immunology77:13-18.
75.
Hammerle CH, Schiodt M., Lackner AA, Armitage GC, Daniels TE, Greenspan IS (1993). Langerhans cells in oral mucosa of rhesus monkeys before and after infection by simian retrovirus-1 and simian immunodeficiency virus. Oral Surg Oral Med Oral Pathol76:742-745.
76.
Hanau D., Schmitt DA (1990). Possible mechanism of action of CD1a antigens. J Invest Dermatol95:503-505.
77.
Hanau D., Fabre M., Schmitt DA, et al. (1987). Human epidermal Langerhans cells internalise by receptor-mediated endocytosis T6 [CD1 "NA1/34"] surface antigen. Birbeck granules are involved in the intracellular traffic of the T6 antigen. J Invest Dermatol89:172-1 77.
78.
Hartman KS ( 1980). Histiocytosis X: a review of 114 cases with oral involvement. Oral Surg Oral Med Oral Pathol49:38-54
79.
Hasseus B., Dahlgren U., Bergenholtz G., Jontell M. (1995). Antigen presenting capacity of Langerhans cells from rat oral epithelium. ) J Oral Pathol Med24:56-60.
80.
Hauser C., Snapper CM, Ohara J., Paul WE, Katz SI ( 1989). T helper cells grown with hapten-modified cultured Langerhans cells produce interleukin-4 and stimulate lgE production by B cells. Eur J Immunol19:245-251.
81.
Heufler C., Topar G., Koch F., et al. (1992). Cytokine gene expression in murine epidermal cell suspensions: interleukin-1 β and macrophage inflammatory protein 1α are selectively expressed in Langerhans cells but are differentially regulated in culture. J Exp Med176:1221-1226.
82.
Hopkins J., Dutia BM, Bujdosa R., McConnell I. (1989). In vivo modulation of CD1 and MHC class II expression by sheep afferent lymph dendritic cells. J Exp Med170:1303-1318.
83.
Hosoi J. Murphy GF, Egan CL, et al. (1993). Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature363:159-163.
laneway CA Jr, Bottomly K. (1994). Signals and signs for lymphocyte responses. Cell76:275-285.
89.
Jones J., Sugiyama M., Watt FM, Speight PM (1993). Integrin expression in normal, hyperplastic, dysplastic and malignant oral epithelium. J Pathol169:235-243.
90.
Juhl M., Stoltze K., Reibel J. (1988). Distribution of Langerhans cells in clinically healthy gingival epithelium with special emphasis on junctional epithelium. Scand J Dent Res96:199-208.
91.
Kashihara M., Ueda M., Horiguchi Y., Furukawa F., Hanaoka M., Imamura S. (1986). A monoclonal antibody specifically reactive to human Langerhans cells J Invest Dermatol87:602-607.
92.
Kasinrerk W., Baumruker T., Majdic O., Knapp W., Stockinger H. (1993). CD1 molecule expression on human monocytes induced by granulocyte-macrophage colony stimulating factor. J Immunol150:579-584.
93.
Katz S.1, Tamaki T., Sachs DH (1979). Langerhans cells are derived from cells originating in bone marrow. Nature282:324-326.
94.
Kinane DF, Drummond JR, Chisholm DM (1990). Langerhans cells in human chronic gingivitis and phenytoin-induced gingival hyperplasia. Arch Oral Biol35:561-564.
95.
Kobayashi Y., Staquet MJ, Dezutter-Dambuyant C., Schmitt D. (1994). Development of motility of Langerhans cell through extracellular matrix by in vitro hapten contact. Eur J Immunol24:2254-2257.
96.
Koch F., Heufler C., Kampgen E., Schneeweiss D., Bock G., Schuler G. (1990). Tumor necrosis factor a maintains the viability of murine epidermal Langerhans cells in culture but, in contrast to granulocyte/macrophage colony-stimulating factor, without inducing their functional maturation. J Exp Med171:159-171.
97.
Koide SL, Steinman RM (1987). Induction of murine interleukin-1: stimuli and responsive primary cells. Proc Natl Acad Sci84:3802-3806.
98.
Koide SL, Inaba K., Steinman RM (1987). lnterleukin-1 enhances T-dependent immune responses by amplifying the function of dendritic cells. J Exp Med165:515-30.
99.
Koszik F., Strunk D., Simonitsch I. Picker L.), Stingl G., Payer E. (1994). Expression of monoclonal antibody of HECA-452-defined E-selectin ligands on Langerhans cells in normal and diseased skin J I Invest Dermatol102:773-780.
100.
Krenacs L., Tiszalvicz L., Krenacs T., Boumsell L. (1993). immunohistochemical detection of CD1a antigen in formalin-fixed and paraffin-embedded tissue sections with monoclonal antibody 010. I Pathol171:99-104.
101.
Kurihara K., Hashimoto N. (1985). The pathological significance of Langerhans cells in oral cancer. J Oral Pathol14:289-298.
102.
Larsen CP, Ritchie SC, Hendrix R., et al. (1994). Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J Immunol152:5208-5219.
103.
Liu H.-N., Yun-Ting C., Wong C.-K. (1995). Enrichment of unlabelled human Langerhans cells by modified discontinuous Ficoll-Metrizoate density medium and following Langerhans cell culture. Clin Exp Dermatol19:113-117.
104.
Lombardi T., Hauser C., Budtz-lørgensen E. (1993). Langerhans cells: structure, function and role in oral pathological conditions. J Oral Pathol Med22:193-202.
105.
Longley J., Kraus J., Alonso M., Edelson R. (1989). Molecular cloning of CD1a (T6j, a human epidermal dendritic cell marker related to class 1 MHC molecules. J Invest Dermatol92:628-631.
106.
Loning T., Caselitz J., Seifert G., Weber K., Osborn M. (1982). Identification of Langerhans cells: use of sera to intermediate filaments, T6 and HLADR in oral mucosa, human epidermis and their tumours. Virchows Arch [ Pathol Anat]398:119-128.
107.
Loning T., Broemel H., Becker WM, Otto HF ( 1983). Identification of inflammatory cell phenotypes in human oral carcinomas by means of monoclonal antibodies. Arch Oral Biol28:1093-1100.
108.
Macatonia SE, Edwards AJ, Knight SC (1986). Dendritic cells and the initiation of contact sensitivity to fluorescein isothiocyanate. Immunology59:509-514.
109.
Macatonia SE, Knight SC, Edwards AJ, Griffiths S., Fryer P. (1987). Localisation of antigen on lymph node dendritic cells after exposure to the contact sensitiser fluorescein isothiocyanate. Functional and morphological studies. J Exp Med166:1654-1667.
110.
Mackenzie IC, Bickenbach JR, Rittman BR (1982). Reactivity of epidermal Langerhans cells to a histochemical method for demonstration of β-glucuronidase. J Invest Dermatol78:239-242.
111.
Martin LH, Calabi F., Milstein C. (1986). Isolation of CD1 genes: a family of MHC-related differentiation antigens. Proc Natl Acad Sci83:9154-9158.
112.
Mishima Y. (1966). Melanosomes in phagocytic vacuoles in Langerhans cells. J Cell Biol30:417-423.
113.
Mommaas AM, Mulder AA, Out CJ, et al. (1995). Distribution of HLA class II molecules in epidermal Langerhans cells in situ. Eur J immunol25:520-525.
114.
Moughal NA, Adonogianaki E., Kinane DF (1992). Langerhans cell dynamics in human gingiva during experimentally induced inflammation. J Biol Buccale20:163-167.
115.
Moulon C., Peguet-Navarro J., Schmitt D. (1991). A potential role for CD1a molecules on human epidermal Langerhans cells in allogeneic T-cell activation. I Invest Dermatol97:524-528.
116.
Murphy GF, Bhan AK, Sato S., Harrist TJ Mihm MC Jr (1981). Characterisation of Langerhans cells by the use of monoclonal antibodies. Lab Invest45:465-468.
117.
Murphy GF, Merot Y., Tong AK, Smith B., Mihm MC ( 1985). Depletion and repopulation of epidermal dendritic cells after allogeneic bone marrow transplantation in humans. J Invest Dermatol84:210-214.
118.
Newcomb GM, Powell RN (1986). The ultrastructure of human gingival Langerhans cells in health and disease. Arch Oral Biol31:727-734.
119.
Newcomb GM, Seymour GJ, Powell RN (1982). Association between plaque accumulation and Langerhans cell numbers in the oral epithelium of attached gingiva. I Clin Perio9:297-304.
120.
Niimi A., Tohnai I., Kaneda T., Takeuchi M., Nagura H. (1990). Immunohistochemical analysis of effects of cyclosporin A on gingival epithelium. J Oral Pathol Med19:397-403.
121.
Nylander K., Larsen JK, Larsen J., Clausen H., Bonding N., Dabelsteen E. (1992). The ELAM-1 ligand sialosyl-Lex is present on Langerhans cells isolated from stratified epithelium. Exp Dermatol1:236-241.
122.
Olszewski WL, Grzelak I., Lukonska B., Engeset A. (1983). Passenger cells in normal human skin-phenotypic and functional evaluation. Transpl Proc15:322-325.
123.
Ohno J., Ohshima Y., Arakaki S., Yokoyama S., Utsumi N. (1993). Immunohistochemical detection of sialyl Lex antigen on mucosal Langerhans cells of human oral mucosa following neuraminidase pretreatment. Biotech Histochem68:284-289.
124.
Parkinson EK, Graham GJ, Daubersies P., et al. (1993). Hemopoietic stem cell inhibitor (SCI/MIP-1α) also inhibits clonogenic epidermal keratinocyte proliferation. J Invest Dermatol101:113-117.
125.
Paul WE, Seder RA (1994). Lymphocyte responses and cytokines. Cell76:241-251.
126.
Perrault C., Pelletier M., Landry D., Gyger M. (1984). Study of Langerhans cells after allogeneic bone marrow transplantation. Blood63:807-811.
127.
Picut CA, Lee CS, Dougherty BA, Anderson KL, Lewis RM (1988). Immunostimulatory capabilities of highly enriched Langerhans cells in vitro. J Invest Dermatol90:201-206.
128.
Pitigala-Arachchi A., Crane IJ, Scully C., Prime SS (1989). Epithelial dendritic cells in pathological human oral tissues. I Oral Pathol Med18:11-16.
129.
Pope M., Betjes MGH, Hirmand H., Hoffman L., Steinman RM (1995). Both dendritic cells and memory T lymphocytes emigrate from organ cultures of human skin and form distinctive dendritic-T-cell conjugates. J Invest Dermatol104:11-17.
130.
Porcelli S., Brenner MB, Greenstein JL, Balk SP, Terhorst C., Bleicher PA (1989). Recognition of cluster of differentiation I antigens by human CD4-CD8- cytolytic T lymphocytes. Nature341:447-450.
131.
Pure E., Inaba K., Metlay J. (1988). Lymphokine production by murine T-cells in the mixed leucocyte reaction. J Exp Med168:795-800.
132.
Raber-Durlacher JE, Leene W., Palmer-Bouva CC, Raber J., Abraham-Inpijn L. (1993). Experimental gingivitis during pregnancy and post-partum: immunohistochemical aspects. J Periodontol64:211-218.
133.
Reis e Sousa C., Stahl PD, Austyn JM (1993). Phagocytosis of antigens by Langerhans cells in vitro. J Exp Med178:509-519.
134.
Romani N., Lenz A., Glassl H., et al. (1989a). Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. J Invest Dermatol93:600-609.
135.
Romani N., Koide S., Crowley M., et al. (1989b). Presentation of exogenous protein antigens by dendritic cells to T-cell clones. Intact protein is presented best by immature epidermal Langerhans cells. J Exp Med169:1169-1178.
136.
Ross EL, Barker JN, Allen MH, Chu AC, Groves RW, MacDonald DM (1994). Langerhans' cell expression of the selectin ligand, sialyl Lewis X. Immunology81:303-308.
137.
Rowden G. (1981). The Langerhans cell. CRC Crit Rev Immunol3:95-180.
138.
Sagebiel RW, Reed TH ( 1968). Serial reconstruction of the characteristic granule of the Langerhans cell. J Cell Biol36:595-602.
139.
Savage NW, Walsh LJ, Seymour GJ (1987). Expression of class I and II major histocompatibility complex antigens on oral mucosal epithelium. J Oral Pathol16:153-157.
140.
Schmitt DA, Hanau D., Casenave J-P. (1989). Isolation of epidermal Langerhans cells. J Immunogenetics16:157-168.
141.
Schmitt DA, Hanau D., Bieber T., et al. (1990). Human epidermal Langerhans cells express only the 40kD Fcγ receptor [FcRII]. J Immunol144:4282-4290.
142.
Schroeder H., Theilade J. (1966) Electron microscopy of normal human gingival epithelium. J Periodont Res1:95-119,
143.
Schuler G., Steinman RM (1985) Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med161:526-546.
144.
Scott J. Valentine JA, St Hill CA, Balasooriya BAW (1983). A quantitative histological analysis of the effects of age and sex on human lingual epithelium. J Biol Buccale11:303-315.
145.
Shelley WB, Juhlin L. (1976). Langerhans cells form a reticuloepithelial trap for external contact allergens. Nature261:46-47.
146.
Shimada S. Wright Caughman S., Sharrow SO, Stephany D., Katz SI ( 1987). Enhanced antigen-presenting capacity of cultured Langerhans cells is associated with markedly increased expression of Ia antigen. I Immunol139:2551-2555.
147.
Simon JC, Cruz PD lr, Tigelaar RE, Sontheimer RD, Bergstresser PR (1991a). Adhesion molecules CD1 la, CD18 and ICAM-1 on human epidermal Langerhans cells serve a functional role in the activation of alloreactive T-cells. I Invest Dermatol96:148-151.
148.
Simon JC, Bergstresser PR, Cruz PD Jr (1991b). Diminished antigen presenting function by freshly isolated epidermal Langerhans cells: possible explanations based on methodology. J Invest Dermatol96:995.
149.
Solcia E., Paulli M., Silini E., et al. (1993). Cathepsin E in antigen-presenting Langerhans and interdigitating reticulum cells. Its possible role in antigen processing. Eur J Histochem37:19-26.
150.
Stewart JC, Regezi JA, Lloyd RV, McClatchey KD (1986). Immunohistochemical study of idiopathic histiocytosis of the mandible and maxilla. Oral Surg Oral Med Oral Pathol61:48-53.
151.
Streilein JW, Grammer SF (1989). In vitro evidence that LC can adapt to functionally distinct forms capable of antigen presentation to T lymphocytes. J Immunol143:3925-3933.
152.
Symington FW, Brady W., Linsley PS (1993). Expression and function of B7 on human epidermal Langerhans cells. J Immunol150:1286-1295.
153.
Tazi A., Bouchonnet F., Grandsaigne M., Boumsell L., Hance AJ, Soler P. (1993). Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers. J Clin Invest91:566-576.
154.
Teunissen MBM, Wormeester J., Krieg SR, Peters PJ, Vogels IMC, Kapsenberg ML, et al. (1990). Human epidermal Langerhans cells undergo profound morphologic and phenotypic changes during in vitro culture. J Invest Dermatol94:166-173.
155.
Teunissen MBM, de Jager MH, Kapsenberg ML, Bos JD (1991). Inhibitory effect of cyclosporin A on antigen and alloantigen presenting capacity of human epidermal Langerhans cells. Br J Dermatol125:309-316.
156.
Teunissen MB, Rongen HA, Bos JD (1994). Function of adhesion molecules lymphocyte function-associated antigen-3 and intercellular adhesion molecule-1 on human epidermal Langerhans cells in antigen-specific T-cell activation. J Immunol152:3400-3409.
157.
Tew JG, Thorbecke GJ, Steinman RM (1982). Dendritic cells in the immune response: characteristics and recommended nomenclature (a report from the RES Society Committee on Nomenclature). RES: J Reticuloendoth Soc31:371-380.
158.
Tiegs SL, Evavold BD, Yokohama A., Stec S., Quintans J., Rowley D. (1990). Delayed antigen presentation by epidermal Langerhans cells to cloned Th, and Th2 cells. J Invest Dermatol95:446-449.
159.
Torresani C., Manara GC, Ferrari C., de Panfilis G. (1991). Immunoelectron microscopic characterisation of a subpopulation of freshly isolated epidermal Langerhans cells that reacts with anti-CD23 monoclonal antibody. Br J Dermatol124:533-537.
160.
van de Rijn M., Lerch PG, Bronstein BR, Knowles RW, Bhan AK, Terhorst C. (1984). Human cutaneous dendritic cells express two glycoproteins T6 and M241 which are biochemically identical to those found on cortical thymocytes. Hum Immunol9:201-210.
161.
van Heerden WFP, Raubenheimer EJ, van Rensburg EJ, le Roux R. (1995). Lack of correlation between DNA ploidy, Langerhans cell population and grading in oral squamous cell carcinoma. J Oral Pathol Med24:61-65.
162.
van Hoogstraten IMW, Andersen KE, von Blomberg BM, et al. (1991). Reduced frequency of nickel allergy upon oral nickel contact at an early age. Clin Exp Immunol85:441-445.
163.
van Loon LAJ, van Elsas PW, Bos JD, Ten Harkel-Hagenaar HC, Krieg SR, Davidson CL (1988). T-lymphocyte and Langerhans cell distribution in normal and allergically induced oral mucosa in contact with nickel-containing dental alloys. J Oral Pathol17:129-137.
164.
van Loon LAJ, Krieg SR, Davidson CL, Bos JD (1989). Quantification and distribution of lymphocyte subsets and Langerhans cells in normal human oral mucosa and skin. J Oral Pathol Med18:197-201.
165.
van Wilsem EJ,van Hoogstraten IMW, Breve J., Scheper RJ, Kraal G. (1994a). Dendritic cells of the oral mucosa and the induction of oral tolerance. A local affair. Immunology83:128-132.
166.
van Wilsem EJ, Breve J., Kleijmeer M., Kraal G. (1994b). Antigen-bearing Langerhans cells in skin draining lymph nodes: phenotype and kinetics of migration. J Invest Dermatol103:217-220.
167.
Volc-Platzer B., Stingl G., Wolff K., Hinterberg W., Schnedl W. (1984). Cytogenetic identification of allogeneic epidermal Langerhans cells in a bone marrow graft recipient. N Engl J Med310:1123-1126.
168.
Walsh LJ, Seymour GJ (1988). Interleukin-1 induces CD1 antigen expression on human gingival epithelial cells. J Invest Dermatol90:13-16.
169.
Walsh LJ, Seymour GJ, Powell RN (1986). Modulation of class II [DR and DQ] antigen expression on gingival Langerhans cells by γ-interferon and prostaglandin E2. J Oral Pathol15:347-351.
170.
Walsh LJ, Seymour GJ, Powell RN (1987a). Differential expression of class II (DR and DQ) antigens by human gingival Langerhans' cells and keratinocytes in vitro. J Oral Pathol16:27-30.
171.
Walsh LJ, Lander PE, Seymour GJ, Powell RN (1987b). In vitro modulation of T6 expression on gingival Langerhans cells by interleukin-1 inhibitors and ETAF. J Dent Res66:766-769.
172.
Walsh LJ, Seymour GJ, Powell RN (1990a). Human gingival Langerhans cells stimulate allogeneic lymphocytes: requirements for MHC class II antigens. I Periodontol61:328-333.
173.
Walsh LJ, Ishii T., Savage NW, Gemmell E., Seymour GJ (1990b). Immunohistologic analysis of epithelial cell populations in oral lichen planus. J Oral Pathol Med19:177-181.
174.
Walsh L.), Cleveland DB, Cumming DB (1992). Quantitative evaluation of Langerhans cells in median rhomboid glossitis. J Oral Pathol Med21:28-32.
175.
Walton LJ, Thornhill MH, Farthing PM (1994). VCAM-1 and ICAM-1 are expressed by Langerhans cells, macrophages and endothelial cells in oral lichen planus. J Oral Pathol Med23:262-268.
176.
Waterhouse JP, Squier CA (1967). The Langerhans cell in human gingival epithelium. Arch Oral Biol12:341-348.
177.
Wolff K., Winkelmann RK (1967). Ultrastructural localisation of nucleoside triphosphatase in Langerhans cells. J Invest Dermatol48:50-54.
178.
Yu RC, Chu C., Buluwela L., Chu AC (1994). Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet343:767-768.
179.
Zelickson AS, Mottaz JH (1968). Localisation of gold chloride and ATPase in human Langerhans cells. J Invest Dermatol51:365-372.
